Literature DB >> 22583358

K-ras mutations are correlated to lymph node metastasis and tumor stage, but not to the growth pattern of colon carcinoma.

Abdul Mannan1, Victoria Hahn-Strömberg.   

Abstract

In colorectal carcinoma, pathological assessment of tumors is essential for determining therapy and prognosis of the disease. Molecular associations of tumor complexity index and genetic alternations can be helpful to understand the tumor progression mechanism. Oncogenic K-ras is one of the major colorectal cancer associated genes, and is mutated in up to 50% of colorectal cancers. In this current study, we correlated tumor complexity index with mutations in K-ras codon 12, 13, and 61 in association with different clinicopathological parameters such as TNM stage, localization, sex, and age. Formalin-fixed paraffin embedded tissue blocks from colon cancer samples was selected from 88 patients diagnosed with adenocarcinoma. Mutations in the K-ras gene were detected using pyrosequencing technique. Tumor complexity index was calculated using immunohistochemically stained images of the tumor outline of the specimens and then analyzing these pictures using Photoshop CS, Fovea Pro, and Image J computer programs. Statistical analysis was performed with SPSS. K-ras mutations were detected in 17 (19.3%) colon cancer samples. Most of the samples were at a lower complexity index. No correlation was observed between K-ras mutations and complexity index. However, K-ras mutations were correlated with regional lymph node metastasis and tumor stages and complexity index with tumor wall penetration. In conclusion, complexity index and K-ras mutations are independent events; however, both correlate with tumor progression and are important in the biologic development of colon carcinoma.
© 2011 The Authors. APMIS © 2011 APMIS.

Entities:  

Mesh:

Year:  2011        PMID: 22583358     DOI: 10.1111/j.1600-0463.2011.02852.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Clinical retrospective study on the expression of the PD-L1 molecule in sporadic colorectal cancer and its correlation with K-ras gene mutations in Chinese patients.

Authors:  Jiasheng Xu; Wenpeng Zhao; Kaili Liao; Luxia Tu; Xiaozhen Jiang; Hua Dai; Yanqing Yu; Qiuying Xiong; Zhenfang Xiong
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Relationships between KRAS mutation status and baseline radiographic distribution of disease in patients with stage IV colorectal cancer.

Authors:  Michael H Rosenthal; Kyung Won Kim; Charles S Fuchs; Jeffrey A Meyerhardt; Nikhil H Ramaiya
Journal:  Abdom Imaging       Date:  2014-12

3.  High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients.

Authors:  Katharina Ilm; Wolfgang Kemmner; Marc Osterland; Susen Burock; Gudrun Koch; Pia Herrmann; Peter M Schlag; Ulrike Stein
Journal:  Mol Cancer       Date:  2015-02-14       Impact factor: 27.401

4.  Gene and isoform expression signatures associated with tumor stage in kidney renal clear cell carcinoma.

Authors:  Qi Liu; Shilin Zhao; Pei-Fang Su; Shyr Yu
Journal:  BMC Syst Biol       Date:  2013-12-09

5.  Investigating the association between polymorphisms in connective tissue growth factor and susceptibility to colon carcinoma.

Authors:  Abrar Ahmad; Shlear Askari; Rahel Befekadu; Victoria Hahn-Strömberg
Journal:  Mol Med Rep       Date:  2014-12-11       Impact factor: 2.952

6.  Oncogenic Kras drives invasion and maintains metastases in colorectal cancer.

Authors:  Adam T Boutin; Wen-Ting Liao; Melody Wang; Soyoon Sarah Hwang; Tatiana V Karpinets; Hannah Cheung; Gerald C Chu; Shan Jiang; Jian Hu; Kyle Chang; Eduardo Vilar; Xingzhi Song; Jianhua Zhang; Scott Kopetz; Andrew Futreal; Y Alan Wang; Lawrence N Kwong; Ronald A DePinho
Journal:  Genes Dev       Date:  2017-03-13       Impact factor: 11.361

7.  Inducible Intestine-Specific Expression of krasV12 Triggers Intestinal Tumorigenesis In Transgenic Zebrafish.

Authors:  Jeng-Wei Lu; Divya Raghuram; Pei-Shi Angelina Fong; Zhiyuan Gong
Journal:  Neoplasia       Date:  2018-11-01       Impact factor: 5.715

8.  Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report.

Authors:  Fatima El Agy; Sanae El Bardai; Ihsane El Otmani; Zineb Benbrahim; Ibn Majdoub Hassani Karim; Khalid Mazaz; El Bachir Benjelloun; Abdelmalek Ousadden; Mohammed El Abkari; Sidi Adil Ibrahimi; Laila Chbani
Journal:  PLoS One       Date:  2021-03-30       Impact factor: 3.240

9.  Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.

Authors:  Rupal Sinha; Showket Hussain; Ravi Mehrotra; R Suresh Kumar; Kapil Kumar; Pankaj Pande; Dinesh Chandra Doval; Seemi Farhat Basir; Mausumi Bharadwaj
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.